BEE VECTORING TECHNOLOGIES INTERNATIONAL INC. (via TheNewswire)
 | |||||||||
 |  |  |  | ||||||
“Investing in this research is crucial for understanding the potential market for a CR-7 seed treatment product,” said
“Two years of rigorous testing confirmed CR-7’s exceptional safety profile on soybean seeds, showing no signs of toxicity or adverse effects on plant health,” said Dr.
The seed treatment market is a significant new revenue opportunity for the Company. Through a future licensing agreement, BVT could potentially reap significant annual royalties from this application.
“We continue to progress our collaborations with major global multinationals,” said
Research highlights include:
Extended Viability: CR-7 demonstrates a long shelf life once it is coated on soybean seeds. This is a key metric for seed treatments since seeds may not be planted for 6-12 months post-treatment, thus giving BVT sales partners a strong value proposition and a robust product. This shelf-life study in ongoing.
Compatibility with other seed treatments: Testing confirms CR-7's compatibility with other seed treatment products, including biologicals and chemical pesticides, ensuring it fits seamlessly into existing agricultural practices where multiple products are applied to the seed at the same time.
Proven Safety: Extensive safety tests show that CR-7 does not harm soybean plant germination or growth, maintaining plant health from seed through maturity.
Additional observations from BVT’s R&D team included:
No observation of negative interactions between CR-7 and other microbes.
CR-7 demonstrated significant compatibility with a number of major and commonly used fungicides.
After nine months, CR-7 remains detectable in seedlings, demonstrating that it stays dormant until activated by a live host. This underscores its robust and enduring shelf life.
“Our ongoing R&D efforts continue to showcase the robustness of CR-7, with promising results indicating its effectiveness remains intact for up to nine months and potentially beyond,” continued
Above:A blotter test can be used to detect CR-7. The photos show that CR-7 is growing on soybean root and stem tissue.
Soybeans are the fourth leading crop produced globally.
What’s next? A commercial formulation of the seed treatment product is in development: BVT is now focused on taking this strong proof of concept and turning it into a formulated product.
(1)Source: IISD, Global Market Report: Soybean prices and sustainability, 2024
(2)Source: USDA,
About
BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the
Additional information can be viewed at the Company’s websitewww.beevt.com.To receive regular news updates from the Company, subscribe atwww.beevt.com/newsletter.
BVT Company Contact:
info@beevt.com
BVT Investor Contacts:
Tel: 416-646-6779
bpedram@virtusadvisory.com
The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release.Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, “annual revenue potential”, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: planted acres, selling price of competitive chemical pesticides and the US to Canadian dollar exchange rate. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims, regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, theability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company’s Filing Statement dated
Copyright (c) 2024 TheNewswire - All rights reserved.
Copyright (c) 2024 TheNewswire - All rights reserved., source
